Endobronchial Ultrasound Needle Aspiration With and Without Suction

Not Applicable

• Conditions: Lymphoma; Tuberculosis; EGF-R Positive Non-Small Cell Lung Cancer; ALK Translocation; Sarcoidosis; Mediastinal Lymphadenopathy; Hilar Lymphadenopathy; PDL1 Gene Mutation; Lung Neoplasms; ROS1 Gene Mutation
• Interventions: Procedure: No suction EBUS-TBNA; Procedure: Passive suction through dedicated EBUS-TBNA syringe; Procedure: Manual applied suction EBUS-TBNA through a pistol-grip syringe holder

• Registration Number: NCT05110950
• Lead Sponsor: Università Politecnica delle Marche

Brief Summary

The main purpose of the present study is to compare the diagnostic yield of different aspiration techniques in Ultrasound-guided Transbronchial Needle Aspiration (EBUS-TBNA) in the diagnosis of hilar/mediastinal adenopathy

Detailed Description

The role of ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) for the diagnosis of hilar/mediastinal adenopathy is well established. However, different aspiration techniques are available and it's not clear if there's a significant difference between suction vs no suction aspiration. Of great interest is the role of different aspiration techniques in EBUS-TBNA in determining the diagnostic yield for histopathological evaluation, including molecular biology and PD-L1 amplification assessment in lung cancer diagnosis.

In this context, no comparative studies between suction and no suction aspiration have been performed; moreover, considering only suction techniques, no studies evaluated if there's a difference between aspiration with EBUS dedicated syringe and manual aspiration through Cameco syringe. It is very important for clinical practice to definitively assess the non inferiority of no suction techniques in EBUS-TBNA in terms of diagnostic yield, and to provide information regarding the quality of histologic sample to define the best diagnostic strategy.

The study is focused on a minimum of 306 patients who have at least one hilar/mediastinal lymph node \> 1 cm on CT scan or hypermetabolic on FDG-PET in at least one approachable lymph nodal station for which a diagnostic cyto-histological assessment is required for clinical purpose. Patients will be randomized 1:1:1 (no suction : passive suction with EBUS dedicated syringe : manual suction with Cameco syringe) by a computer-generated random-allocation system to undergo EBUS-TBNA with one of the three different aspiration techniques. The pathologist provides a final diagnosis and, as secondary endpoint, a qualitative assessment of the sample quality using both a binary and a semi-quantitative score.

Study Timeline

• Study First Submitted: 2021-10-27
• Study First Submitted QC: 2021-10-27
• Study First Posted: 2021-11-08
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-25
• Last Update Posted: 2022-05-26
• Study Start: 2022-06-01
• Primary Completion: 2022-06-26
• Study Completion: 2024-06-26

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 306

Inclusion Criteria

• age ≥ 18years;
• presence of at least one hilar/mediastinal adenopathy >1 cm on short axis assessed by contrast-enhanced CT scan and/or hypermetabolic adenopathy assessed by FDG-PET;
• ability to give an informed consent

Exclusion Criteria

• coagulopathy or bleeding diathesis that cannot be corrected;
• severe refractory hypoxemia;
• unstable hemodynamic status;
• inability to give an informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
No suction EBUS-TBNA	No suction EBUS-TBNA	In this technique the stylet is slowly removed without any kind of device in order to avoid active suction.
Passive suction through dedicated EBUS-TBNA syringe	Passive suction through dedicated EBUS-TBNA syringe	After rapid stylet removal, suction is applied through a vacuteiner syringe, without active aspiration.
Manual applied suction EBUS-TBNA through a pistol-grip syringe holder	Manual applied suction EBUS-TBNA through a pistol-grip syringe holder	After rapid stylet removal, suction is applied through Cameco syringe pistol, that can apply active suction manually.

Primary Outcome Measures

Name	Time	Method
To compare the diagnostic yield of active suction vs passive suction vs no suction EBUS-TBNA in the diagnosis of hilar/mediastinal adenopathies	36 months	The diagnostic yield is defined as the rate of diagnoses/total of cases. Assuming that the best technique provides a diagnostic yield of 94%, the non inferiority is defined if the difference between the best and the worst method is less than 3% with a non-inferiority limit of 10%.

Secondary Outcome Measures

Name	Time	Method
Adeguacy for molecular assessment in lung cancer	36 months	Considering only the lung cancer diagnoses, the sample is considered adeguated is if provides all the available molecular evaluations included PD-L1 iperexpression
Qualitative evaluation of the sample by the pathologist	36 months	The sample is evaluated by a pathologist that provides a semi-quantitative assessment of the sample, through a cell count: the sample is adeguate only if it contains more than diagnostic 100 cells.

Trial Locations

Locations (1)

Pulmonary Diseases Unit, Department of Immunoallergic and Respiratory Diseases, Azienda Ospedaliero Universitaria 'Ospedali Riuniti' Ancona; 🇮🇹 Ancona, Italy